23andme
(2)
Brad Kittredge
Brad Kittredge is the co-founder and CEO of Brightside Health, a San Francisco-based telemental health platform serving 135 million covered lives across commercial insurance, Medicare, and Medicaid. Driven by his father's decade-long struggle to find effective depression treatment, Kittredge built Brightside from a two-day old Stripe notification into the first telepsychiatry company to achieve 100% national Medicare Part B coverage. Before Brightside, he led product teams at 23andMe and Lantern, and built ComplexDx - later acquired by 23andMe. He holds an MBA, MPH, MA in International Affairs, and a BA in Psychology, all from UC Berkeley and UC San Diego.
Paul Johnson
Paul Johnson is a British-American entrepreneur, author, CEO coach, and General Partner at Flex Capital — a $200M+ venture fund backing 200+ category-defining companies including Perplexity, Vercel, Rippling, and Supabase. He founded Lemonaid Health in San Francisco in 2013, pioneering nationwide digital telehealth and prescription delivery, raised $60M+, scaled to nearly 200 employees, and sold the company to 23andMe for $400 million in 2021. Since then, he has written two Nobel laureate biographies, coaches high-growth CEOs, and invests in early-stage AI and fintech startups — while competing in professional-level pickleball tournaments.